These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN. Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663 [Abstract] [Full Text] [Related]
12. The risk factors and symptomatology of perimenopausal depression. Oztürk O, Eraslan D, Mete HE, Ozşener S. Maturitas; 2006 Sep 20; 55(2):180-6. PubMed ID: 16581210 [Abstract] [Full Text] [Related]
13. A surveillance study of escitalopram treatment of depressed patients. Anders M, Tuma I, Rösslerova H. Expert Opin Pharmacother; 2008 Jan 20; 9(1):1-6. PubMed ID: 18076333 [Abstract] [Full Text] [Related]
15. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV. Clin Ther; 2007 Nov 20; 29(11):2319-32. PubMed ID: 18158074 [Abstract] [Full Text] [Related]
20. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. Malhi GS, Ng F, Berk M. Aust N Z J Psychiatry; 2008 Apr 20; 42(4):346-9. PubMed ID: 18330778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]